SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 222 filers reported holding SHOCKWAVE MED INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80 | -29.8% | 400 | 0.0% | 0.02% | -24.2% |
| Q2 2023 | $114 | +31.0% | 400 | 0.0% | 0.03% | +32.0% |
| Q1 2023 | $87 | +6.1% | 400 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $82 | -99.9% | 400 | 0.0% | 0.02% | -30.6% |
| Q3 2022 | $111,000 | +46.1% | 400 | 0.0% | 0.04% | +56.5% |
| Q2 2022 | $76,000 | -8.4% | 400 | 0.0% | 0.02% | +4.5% |
| Q1 2022 | $83,000 | +16.9% | 400 | 0.0% | 0.02% | +22.2% |
| Q4 2021 | $71,000 | -13.4% | 400 | 0.0% | 0.02% | -21.7% |
| Q3 2021 | $82,000 | +7.9% | 400 | 0.0% | 0.02% | +4.5% |
| Q2 2021 | $76,000 | +46.2% | 400 | 0.0% | 0.02% | +22.2% |
| Q1 2021 | $52,000 | +26.8% | 400 | 0.0% | 0.02% | +12.5% |
| Q4 2020 | $41,000 | +36.7% | 400 | 0.0% | 0.02% | +23.1% |
| Q3 2020 | $30,000 | +57.9% | 400 | 0.0% | 0.01% | +44.4% |
| Q2 2020 | $19,000 | +46.2% | 400 | 0.0% | 0.01% | +28.6% |
| Q1 2020 | $13,000 | -27.8% | 400 | 0.0% | 0.01% | -12.5% |
| Q4 2019 | $18,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |